ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,683,000 | -11.7% | 93,732 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,907,000 | -6.5% | 93,732 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,040,000 | -29.8% | 93,732 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,905,000 | +20.9% | 93,732 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,403,000 | +25.6% | 93,732 | -0.5% | 0.00% | +50.0% |
| Q2 2022 | $1,913,000 | -17.9% | 94,204 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,331,000 | -28.8% | 94,204 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $3,273,000 | +28.1% | 94,204 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $2,555,000 | +4.6% | 94,204 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,442,000 | +20.3% | 94,204 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $2,030,000 | 0.0% | 94,204 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $2,030,000 | +45.7% | 94,428 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $1,393,000 | +8606.2% | 94,428 | +13467.2% | 0.00% | – |
| Q2 2020 | $16,000 | -42.9% | 696 | +74.0% | 0.00% | – |
| Q2 2018 | $28,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |